Acuta Capital Partners, LLC Sutro Biopharma, Inc. Call Options Transaction History
Acuta Capital Partners, LLC
- $70.3 Million
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding STRO
# of Institutions
127Shares Held
59.9MCall Options Held
203KPut Options Held
33.6K-
Suvretta Capital Management, LLC New York, NY7.46MShares$14 Million0.57% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$12.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.21MShares$7.87 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.64MShares$6.81 Million0.42% of portfolio
-
Vestal Point Capital, LP New York, NY2.57MShares$4.81 Million0.28% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $97.5M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...